Goasdoué G

University of Bretagne Occidentale, Brest, France.

2 papers

ArticlePsychedelics

Response to: Swieczkowski D, Kwaśny A, Cubała WJ. Regulatory context for protocol amendments and public reporting in psychedelic trials.

Žuljević MF, Mijatović A, Orhanović R +2

Europe PMC2026
ArticlePsilocybin

Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin.

Žuljević MF, Mijatović A, Orhanović R +2

Europe PMC2026